Medications

Triple inhaled therapy aids in moderate-to-very severe COPD

(HealthDay)—Triple therapy, including glucocorticoid at either of two dose levels, is beneficial for moderate-to-very severe chronic obstructive pulmonary disease (COPD), according to a study published online June 24 in ...

Diseases, Conditions, Syndromes

Young, but vulnerable to COVID-19

Although populations in countries in the Global South are on average younger than in Europe, they might be more vulnerable to severe forms of COVID-19. One reason for this is the higher proportion of people at working age ...

page 4 from 45